Ağrı. 2023; 35(3): 181-182 | DOI: 10.14744/agri.2022.79803 | |||
Because little evidence of adverse effects is included in the guidelines for the pharmacological treatment of many diseases, it causes “Pregabalinophobia”Katsuhiro TodaDepartment of Orthopedic Surgery, Hiroshima Clinic, Hiroshima, JapanKeywords: Pregabalinophobia, pharmacological treatment, adverse effect, pregabalin, guidelines, fibromyalgia Birçok hastalığın farmakolojik tedavisine yönelik kılavuzlarda yan etkilere ilişkin çok az kanıt yer aldığından, “Pregabalinofobi “ye neden olmaktadırKatsuhiro TodaHiroşima Kliniği, Ortopedik Cerrahi Bölümü, Hiroşima, JaponyaKatsuhiro Toda. Because little evidence of adverse effects is included in the guidelines for the pharmacological treatment of many diseases, it causes “Pregabalinophobia”. Ağrı. 2023; 35(3): 181-182 Corresponding Author: Katsuhiro Toda, Japan |
|